Ester bonds in prodrugs

ACS Chemical Biology

Volumn 3, Issue 4, 2008, Pages 203-206

  Lavis, Luke D ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA LACTAM; CALCEIN; CARBOHYDRATE DERIVATIVE; ENALAPRIL; ESTER DERIVATIVE; FLUORESCEIN DIACETATE; PRODRUG; ESTER;

CHEMICAL BOND; DRUG STRUCTURE; ENZYME ACTIVITY; HYDROLYSIS; IN VIVO STUDY; METABOLIC ENGINEERING; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; ARTICLE; CHEMISTRY;

ESTERS; PRODRUGS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 44349100368     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb800065s     Document Type: Review

References (26)

1. Campbell, C. T., Sampathkumar, S. G., and Yarema, K. J. (2007) Metabolic oligosaccharide engineering: perspectives, applications, and future directions, Mol. BioSyst. 3, 187-194.
2. Aich, U., Campbell, C. T., Elmouelhi, N., Weier, C. A., Sampathkumar, S.-G., Choi, S. S., and Yarema, K. J. (2008) Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression, ACS Chem. Biol. 3, 230-240.
3. Jones, M. B., Teng, H., Rhee, J. K., Lahar, N., Baskaran, G., and Yarema, K. J. (2004) Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids, Biotechnol. Bioeng. 85, 394-405.
4. Davie, J. R. (2003) Inhibition of histone deacetylase activity by butyrate, J. Nutr. 133, 2485-2493.
5. Testa, B., and Mayer, J. M. (2003) Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology, Verlag Helvetica Chimica Acta, Zürich, Switzerland.
6. Song, X., Xu, C. R., He, H. T., and Siahaan, T. J. (2002) Synthesis of a novel cyclic prodrug of RGD peptidomimetic to improve its cell membrane permeation, Bioorg. Chem. 30, 285-301.
7. Bender, D. M., Peterson, J. A., McCarthy, J. R., Gunaydin, H., Takano, Y., and Houk, K. N. (2008) Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability, Org. Lett. 10, 509-511.
8. Patchett, A. A. (1984) The chemistry of enalapril, Br. J. Clin. Pharmacol. 18, 201S-207S.
9. Rotman, B., and Papermaster, B. W. (1966) Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters, Proc. Natl. Acad. Sci. U.S.A. 55, 134-141.
10. Tsien, R. Y. (1981) A non-disruptive technique for loading calcium buffers and indicators into cells, Nature 290, 527-528.
11. Haugland, R. P., Spence, M. T. Z., Johnson, I. D., and Basey, A. (2005) The Handbook: A Guide to Fluorescent Probes and Labeling Technologies, 10th ed., Molecular Probes, Eugene, OR.
12. Lavis, L. D., Chao, T.-Y., and Raines, R. T. (2006) Fluorogenic label for biomolecular imaging, ACS Chem. Biol. 1, 252-260.
13. Tsien, R. Y. (1980) New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures, Biochemistry 19, 2396-2404.
14. Minta, A., Kao, J. P., and Tsien, R. Y. (1989) Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores, J. Biol. Chem. 264, 8171-8178.
15. Ferres, H. (1980) Pro-drugs of β-lactam antibiotics, Chem. Ind. 435-440.
16. Ouyang, H., Borchardt, R. T., and Siahaan, T. J. (2002) Steric hindrance is a key factor in the coupling reaction of (acyloxy) alkyl-α-halides with phenols to make a new promoiety for prodrugs, Tetrahedron Lett. 43, 577-579.
17. Leroy, E., Bensel, N., and Reymond, J.-L. (2003) A low background high-throughput screening (HTS) fluorescence assay for lipases and esterases using acyloxymethylethers of umbelliferone, Bioorg. Med. Chem. Lett. 13, 2105-2108.
18. Kass, L. (1979) Cytochemistry of esterases, CRC Crit. Rev. Clin. Lab Sci. 10, 205-223.
19. Leinweber, F.-J. (1987) Possible physiological roles of carboxylic ester hydrolases, Drug Metab. Rev. 18, 379-439.
20. Satoh, T., and Hosokawa, M. (1998) The mammalian carboxylesterases: from molecules to functions, Annu. Rev. Pharmacol. Toxicol. 38, 257-288.
21. Rooseboom, M., Commandeur, J. N. M., and Vermeulen, N. P. E. (2004) Enzyme-catalyzed activation of anticancer prodrugs, Pharmacol. Rev. 56, 53-102.
22. Foster, L. J., de Hoog, C. L., Zhang, Y., Zhang, Y., Xie, X., Mootha, V. K., and Mann, M. (2006) A mammalian organelle map by protein correlation profiling, Cell 125, 187-199.
23. Slayman, C. L., Moussatos, V. V., and Webb, W. W. (1994) Endosomal accumulation of pH indicator dyes delivered as acetoxymethyl esters, J. Exp. Biol. 196, 419-438.
24. Grilli, M., Pizzi, M., Memo, M., and Spano, P. F. (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation, Science 274, 1383-1385.
25. 2 synthase, Nat. Struct. Biol. 2, 637-643.
26. Nielsen, N. M., and Bundgaard, H. (1989) Evaluation of glycolamide esters and various other esters of aspirin as true aspirin prodrugs, J. Med. Chem. 32, 727-734.